ko	pathway	ratio_in_study	ratio_in_pop	p_value
ko04380	Osteoclast differentiation	36/389	134/7206	2.13244441113e-16
ko04060	Cytokine-cytokine receptor interaction	41/389	191/7206	8.2968495898e-15
ko04621	NOD-like receptor signaling pathway	36/389	157/7206	4.67118067804e-14
ko04668	TNF signaling pathway	31/389	120/7206	9.23575989366e-14
ko05164	Influenza A	36/389	167/7206	3.48166267165e-13
ko05140	Leishmaniasis	24/389	75/7206	3.78736781946e-13
ko04064	NF-kappa B signaling pathway	26/389	96/7206	3.01437256363e-12
ko04620	Toll-like receptor signaling pathway	25/389	100/7206	5.4500583097e-11
ko05161	Hepatitis B	33/389	173/7206	1.17319005376e-10
ko05162	Measles	27/389	120/7206	1.25059975422e-10
ko05152	Tuberculosis	34/389	187/7206	2.35869301928e-10
ko05321	Inflammatory bowel disease (IBD)	18/389	56/7206	3.28366075021e-10
ko04610	Complement and coagulation cascades	21/389	79/7206	5.75771938587e-10
ko04630	Jak-STAT signaling pathway	27/389	132/7206	1.22546730006e-09
ko05168	Herpes simplex infection	32/389	182/7206	1.97119590241e-09
ko05340	Primary immunodeficiency	12/389	30/7206	1.84767906148e-08
ko05133	Pertussis	20/389	87/7206	2.27748317082e-08
ko04650	Natural killer cell mediated cytotoxicity	21/389	97/7206	3.12927099788e-08
ko05323	Rheumatoid arthritis	20/389	89/7206	3.43902361132e-08
ko05145	Toxoplasmosis	24/389	126/7206	4.52470117594e-08
ko04217	Necroptosis	29/389	178/7206	6.76204423248e-08
ko05150	Staphylococcus aureus infection	12/389	36/7206	1.98822821473e-07
ko05167	Kaposi's sarcoma-associated herpesvirus infection	29/389	191/7206	3.23544491815e-07
ko05144	Malaria	13/389	45/7206	4.06923674069e-07
ko04933	AGE-RAGE signaling pathway in diabetic complications	23/389	135/7206	7.11179995854e-07
ko04659	Th17 cell differentiation	20/389	106/7206	7.19654444694e-07
ko04623	Cytosolic DNA-sensing pathway	12/389	41/7206	9.80478354233e-07
ko05142	Chagas disease (American trypanosomiasis)	22/389	130/7206	1.40103754974e-06
ko04660	T cell receptor signaling pathway	21/389	124/7206	2.41018392596e-06
ko04658	Th1 and Th2 cell differentiation	18/389	96/7206	2.85966955067e-06
ko04657	IL-17 signaling pathway	17/389	87/7206	2.99431961923e-06
ko04210	Apoptosis	26/389	180/7206	3.50172229279e-06
ko05132	Salmonella infection	17/389	98/7206	1.59912903432e-05
ko04622	RIG-I-like receptor signaling pathway	13/389	62/7206	1.99924918544e-05
ko05330	Allograft rejection	8/389	24/7206	2.29766595342e-05
ko05332	Graft-versus-host disease	7/389	18/7206	2.39822560121e-05
ko04662	B cell receptor signaling pathway	15/389	88/7206	6.22535001653e-05
ko05166	HTLV-I infection	32/389	292/7206	0.000102466985671
ko05320	Autoimmune thyroid disease	8/389	29/7206	0.000105630039547
ko04672	Intestinal immune network for IgA production	9/389	37/7206	0.00011433553486
ko05134	Legionellosis	13/389	74/7206	0.000139474351516
ko05160	Hepatitis C	20/389	153/7206	0.000195613566622
ko04940	Type I diabetes mellitus	8/389	32/7206	0.00022441330924
ko04612	Antigen processing and presentation	12/389	77/7206	0.000780646182643
ko04137	Mitophagy - animal	12/389	82/7206	0.00137948432707
ko05310	Asthma	5/389	17/7206	0.00161064402852
ko04640	Hematopoietic cell lineage	10/389	64/7206	0.00206708067638
ko05418	Fluid shear stress and atherosclerosis	19/389	173/7206	0.00305674557613
ko04724	Glutamatergic synapse	1/389	152/7206	0.00327585201449
ko03040	Spliceosome	1/389	145/7206	0.00477340541334
ko05020	Prion diseases	7/389	40/7206	0.0050205143269
ko05034	Alcoholism	4/389	238/7206	0.00531894313758
ko04115	p53 signaling pathway	10/389	74/7206	0.00607333552413
ko05143	African trypanosomiasis	6/389	32/7206	0.00652084338409
ko04917	Prolactin signaling pathway	11/389	87/7206	0.00680902665254
ko04666	Fc gamma R-mediated phagocytosis	14/389	122/7206	0.006928181753
ko04114	Oocyte meiosis	1/389	139/7206	0.00698215707989
ko04066	HIF-1 signaling pathway	14/389	123/7206	0.00730561692472
ko04611	Platelet activation	17/389	163/7206	0.00781098228319
ko05146	Amoebiasis	12/389	99/7206	0.0107038127848
ko05169	Epstein-Barr virus infection	20/389	206/7206	0.0110262923183
ko04932	Non-alcoholic fatty liver disease (NAFLD)	18/389	182/7206	0.0116270064008
ko04068	FoxO signaling pathway	17/389	167/7206	0.013387094784
ko04062	Chemokine signaling pathway	19/389	201/7206	0.0162479822071
ko04145	Phagosome	16/389	162/7206	0.0199306063546
ko04360	Axon guidance	5/389	233/7206	0.0254466481227
ko04144	Endocytosis	28/389	342/7206	0.0263951317528
ko05416	Viral myocarditis	7/389	55/7206	0.0274177566498
ko04920	Adipocytokine signaling pathway	10/389	89/7206	0.0280137111133
ko04727	GABAergic synapse	1/389	110/7206	0.0308180223808
ko04713	Circadian entrainment	2/389	136/7206	0.0342796484444
ko04550	Signaling pathways regulating pluripotency of stem cells	3/389	165/7206	0.0353481414438
ko04664	Fc epsilon RI signaling pathway	9/389	77/7206	0.035779959569
ko04916	Melanogenesis	2/389	142/7206	0.0357995917972
ko04218	Cellular senescence	16/389	177/7206	0.0409657431093
ko04010	MAPK signaling pathway	26/389	321/7206	0.041691486329
ko05131	Shigellosis	9/389	82/7206	0.0421503323365
ko04670	Leukocyte transendothelial migration	14/389	151/7206	0.0431608384605
ko05212	Pancreatic cancer	9/389	83/7206	0.0438350813656
ko04720	Long-term potentiation	1/389	99/7206	0.0438757196953
ko04914	Progesterone-mediated oocyte maturation	1/389	104/7206	0.0450223587934
ko04624	Toll and Imd signaling pathway	6/389	49/7206	0.0468510597386
ko04728	Dopaminergic synapse	4/389	185/7206	0.0468542892856
ko04390	Hippo signaling pathway	4/389	188/7206	0.0474559592283